1. Home
  2. BXC vs XERS Comparison

BXC vs XERS Comparison

Compare BXC & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BXC
  • XERS
  • Stock Information
  • Founded
  • BXC 2004
  • XERS 2005
  • Country
  • BXC United States
  • XERS United States
  • Employees
  • BXC N/A
  • XERS N/A
  • Industry
  • BXC Wholesale Distributors
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BXC Consumer Discretionary
  • XERS Health Care
  • Exchange
  • BXC Nasdaq
  • XERS Nasdaq
  • Market Cap
  • BXC 546.7M
  • XERS 628.7M
  • IPO Year
  • BXC 2004
  • XERS 2018
  • Fundamental
  • Price
  • BXC $68.81
  • XERS $4.51
  • Analyst Decision
  • BXC Strong Buy
  • XERS Strong Buy
  • Analyst Count
  • BXC 5
  • XERS 6
  • Target Price
  • BXC $115.40
  • XERS $6.25
  • AVG Volume (30 Days)
  • BXC 96.2K
  • XERS 2.2M
  • Earning Date
  • BXC 07-29-2025
  • XERS 08-07-2025
  • Dividend Yield
  • BXC N/A
  • XERS N/A
  • EPS Growth
  • BXC N/A
  • XERS N/A
  • EPS
  • BXC 4.53
  • XERS N/A
  • Revenue
  • BXC $2,935,514,000.00
  • XERS $222,551,000.00
  • Revenue This Year
  • BXC $3.40
  • XERS $35.03
  • Revenue Next Year
  • BXC $5.01
  • XERS $18.31
  • P/E Ratio
  • BXC $15.19
  • XERS N/A
  • Revenue Growth
  • BXC N/A
  • XERS 29.88
  • 52 Week Low
  • BXC $63.14
  • XERS $2.03
  • 52 Week High
  • BXC $134.79
  • XERS $6.07
  • Technical
  • Relative Strength Index (RSI)
  • BXC 50.83
  • XERS 46.97
  • Support Level
  • BXC $64.62
  • XERS $4.30
  • Resistance Level
  • BXC $72.13
  • XERS $4.79
  • Average True Range (ATR)
  • BXC 2.70
  • XERS 0.23
  • MACD
  • BXC 0.07
  • XERS -0.01
  • Stochastic Oscillator
  • BXC 47.39
  • XERS 25.93

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: